{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T14:52:18Z","timestamp":1758120738119,"version":"3.37.3"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":80,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004260","name":"People's University of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004260","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.lrr.2024.100457","type":"journal-article","created":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T22:18:41Z","timestamp":1711318721000},"page":"100457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A 95-year-old patient suffered high-grade B-cell lymphoma combined hairy cell leukemia"],"prefix":"10.1016","volume":"21","author":[{"given":"Lingli","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lrr.2024.100457_bib0001","doi-asserted-by":"crossref","DOI":"10.36255\/exon-publications-leukemia-hairy-cell-leukemia","article-title":"Hairy cell leukemia","author":"Janus","year":"2022"},{"issue":"7","key":"10.1016\/j.lrr.2024.100457_bib0002","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/his.12884","article-title":"MYC\/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis","volume":"68","author":"Li","year":"2016","journal-title":"Histopathology"},{"issue":"Suppl Suppl 1","key":"10.1016\/j.lrr.2024.100457_bib0003","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hon.2413","article-title":"Management of aggressive lymphoma in very elderly patients","volume":"35","author":"Thieblemont","year":"2017","journal-title":"Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.lrr.2024.100457_bib0004","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3109\/10428194.2013.810737","article-title":"Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: a population-based cohort study on treatment, toxicity and outcome","volume":"55","author":"Boslooper","year":"2014","journal-title":"Leuk. Lymphoma"},{"issue":"5","key":"10.1016\/j.lrr.2024.100457_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051242","article-title":"Hairy Cell leukemia patients have a normal life expectancy-a 35-year single-center experience and comparison with the general population","volume":"14","author":"Bohn","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"14","key":"10.1016\/j.lrr.2024.100457_bib0006","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1200\/JCO.19.02250","article-title":"Randomized phase II study of first-line cladribine with concurrent or delayed rituximab in patients with hairy cell leukemia","volume":"38","author":"Chihara","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lrr.2024.100457_bib0007","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-018-0779-z","article-title":"Role of Bruton's tyrosine kinase in B cells and malignancies","volume":"17","author":"Pal Singh","year":"2018","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.lrr.2024.100457_bib0008","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1182\/bloodadvances.2018026401","article-title":"Outcomes of patients with relapsed\/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy","volume":"3","author":"Landsburg","year":"2019","journal-title":"Blood Adv."},{"issue":"5","key":"10.1016\/j.lrr.2024.100457_bib0009","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1182\/blood.2020006578","article-title":"A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma","volume":"137","author":"Morschhauser","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.lrr.2024.100457_bib0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.14740\/jh473","article-title":"Durable response to venetoclax monotherapy in Richter's syndrome: a case report and review of literature","volume":"8","author":"Kollipara","year":"2019","journal-title":"J. Hematol."},{"issue":"6","key":"10.1016\/j.lrr.2024.100457_bib0011","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3322\/caac.21357","article-title":"2016 US lymphoid malignancy statistics by World Health Organization subtypes","volume":"66","author":"Teras","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lrr.2024.100457_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1047115","article-title":"High-intensity chemotherapy improved the prognosis of patients with high-grade B-cell lymphoma","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048924000475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048924000475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T17:10:42Z","timestamp":1718903442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048924000475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":12,"alternative-id":["S2213048924000475"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2024.100457","relation":{},"ISSN":["2213-0489"],"issn-type":[{"type":"print","value":"2213-0489"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 95-year-old patient suffered high-grade B-cell lymphoma combined hairy cell leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2024.100457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100457"}}